| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 47 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 47 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 47 |
| 3 | CYTARABINE | 47 |
| 4 | METHOTREXATE SODIUM | 35 |
| 5 | METHOTREXATE | 32 |
| 6 | ETOPOSIDE | 31 |
| 7 | PREDNISONE | 31 |
| 8 | VORICONAZOLE | 31 |
| 9 | VORICONAZOLE INJECTION | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN TOPICAL RECOMBINANT | 2 | 0.0294 |
| 1 | CASPOFUNGIN ACETATE | 17 | 0.0107 |
| 2 | DAUNORUBICIN HYDROCHLORIDE | 11 | 0.0067 |
| 3 | 1169 HYDROGEN PEROXIDE SPRAY | 2 | 0.0065 |
| 4 | HYDROGEN PEROXIDE | 2 | 0.0061 |
| 5 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 2 | 0.0043 |
| 6 | ARSENIC TRIOXIDE | 8 | 0.0035 |
| 7 | GEMTUZUMAB OZOGAMICIN | 12 | 0.0033 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 16 | 0.0025 |
| 9 | GRANULOCYTE COLONY STIMULATING FACTOR | 5 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 91 |
| 1 | Azole Antifungal [EPC] | 72 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 61 |
| 3 | Alkylating Drug [EPC] | 53 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 32 |
| 5 | Topoisomerase Inhibitor [EPC] | 31 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 26 |
| 9 | Kinase Inhibitor [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 12 | 0.0033 |
| 1 | Interferon gamma [EPC] | 2 | 0.0014 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 13 | 0.0010 |
| 4 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 5 | Asparagine-specific Enzyme [EPC] | 9 | 0.0007 |
| 6 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Vitamin K [EPC] | 4 | 0.0005 |
| 9 | Azole Antifungal [EPC] | 72 | 0.0005 |